Jason Arunn Murugesu
Jason Arunn Murugesu
CRITIC
img-contested
N/A
0 reviews
PUBLIC
img-contested
N/A
0 reviews

RECENT ARTICLES

Sort by:
No Rating
Covid-19 news: Moderna’s omicron booster has promising immune response

Covid-19 news: Moderna’s omicron booster has promising immune response

×By , , , , , , , , , , , andModerna’s omicron-tailored booster candidate produces eight times as many virus-neutralising antibodies against the variant as its original booster vaccineAn updated version of Moderna’s covid-19 vaccine that targets the BA.1 sublineage of omicron leads to an eight-fold increase in antibody levels against the variant of concern, according to a small, preliminary .Moderna’s new booster is the first covid-19 vaccine to combine the jab that targeted the original strain of the coronavirus – which emerged in Wuhan, China, at the end of 2019 – with a vaccine that...

May 10, 2020
Share
Save
Review
No Rating
Covid-19 news: Moderna’s omicron booster has promising immune response

Covid-19 news: Moderna’s omicron booster has promising immune response

×By , , , , , , , , , , , andModerna’s omicron-tailored booster candidate produces eight times as many virus-neutralising antibodies against the variant as its original booster vaccineAn updated version of Moderna’s covid-19 vaccine that targets the BA.1 sublineage of omicron leads to an eight-fold increase in antibody levels against the variant of concern, according to a small, preliminary .Moderna’s new booster is the first covid-19 vaccine to combine the jab that targeted the original strain of the coronavirus – which emerged in Wuhan, China, at the end of 2019 – with a vaccine that...

April 9, 2021
Share
Save
Review
No Rating
Covid-19 news: Moderna’s omicron booster has promising immune response

Covid-19 news: Moderna’s omicron booster has promising immune response

×By , , , , , , , , , , , andModerna’s omicron-tailored booster candidate produces eight times as many virus-neutralising antibodies against the variant as its original booster vaccineAn updated version of Moderna’s covid-19 vaccine that targets the BA.1 sublineage of omicron leads to an eight-fold increase in antibody levels against the variant of concern, according to a small, preliminary .Moderna’s new booster is the first covid-19 vaccine to combine the jab that targeted the original strain of the coronavirus – which emerged in Wuhan, China, at the end of 2019 – with a vaccine that...

February 20, 2021
Share
Save
Review
No Rating
Covid-19 news: Moderna’s omicron booster has promising immune response

Covid-19 news: Moderna’s omicron booster has promising immune response

×By , , , , , , , , , , , andModerna’s omicron-tailored booster candidate produces eight times as many virus-neutralising antibodies against the variant as its original booster vaccineAn updated version of Moderna’s covid-19 vaccine that targets the BA.1 sublineage of omicron leads to an eight-fold increase in antibody levels against the variant of concern, according to a small, preliminary .Moderna’s new booster is the first covid-19 vaccine to combine the jab that targeted the original strain of the coronavirus – which emerged in Wuhan, China, at the end of 2019 – with a vaccine that...

April 25, 2020
Share
Save
Review
No Rating
Skeletons reveal wealth gap in Europe began to open 6600 years ago

Skeletons reveal wealth gap in Europe began to open 6600 years ago

×ByA wealth gap may have existed far earlier than we thought, providing insight into the lives of some of .Chelsea Budd at Umeå University in Sweden and her colleagues analysed the 6600-year-old grave sites of the Osłonki community in Poland, to try to determine whether wealth inequality existed in these ancient societies.The team first found that a quarter of the population was . But this doesn’t necessarily mean that these people were richer during their lifetimes.Advertisement“The items could simply have been a performance by the surviving family members,” says Budd. “It could be used to...

August 5, 2020
Share
Save
Review
  • Total 5 items
  • 1
OUTLETS
newscientist.com

newscientist.com

CRITIC
img-contested
N/A
PUBLIC
img-trusted
75%